Burning Rock Biotech (BNR) , a precision oncology company from China, has shown exceptional technical momentum and price appreciation. BNR has surged 405% over the past year, hitting a 2-year high on Wednesday....
Burning Rock Biotech reports Q3 2024 financial results, highlights strategic agreements, product approvals, and revenue growth in precision oncology.Quiver AI SummaryBurning Rock Biotech Limited, a precision...
Engine Capital LP, which owns approximately 1% of Brenntag SE’s (XETRA: BNR) (“Brenntag” or the “Company”) outstanding shares, today announced that it has sent the below letter to members of...
BNR earnings call for the period ending June 30, 2022.
Chinese stocks continue to benefit from a preliminary agreement between the U.S. and China on a long-standing auditing dispute.
GUANGZHOU, China, Aug. 04, 2022 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the...
GUANGZHOU, China, Aug. 03, 2022 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focusing on...
GUANGZHOU, China, July 14, 2022 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the...
CHENGDU, China, June 30, 2022 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the...
GUANGZHOU, China, June 24, 2022 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the...